**About the Special Issue Editor**

**Christian Burri** PhD, is the Deputy Head of the Department of Medicine and the Head of the Medicines Implementation Research Unit at the Swiss TPH, and Professor of Pharmacy & Clinical Pharmacology at the Department of Pharmaceutical Sciences, University of Basel. For almost 25 years, he has been involved in the management and conduct of clinical trials on drugs and vaccines against neglected tropical and poverty-related diseases, mainly in low income countries. In 2018, he handed over this service-oriented responsibility and founded a research group studying the implementation of medicines in resource-low settings in the two main fields of interests of access and pharmacoepidemiology. Throughout his training and professional career, he has had the privilege of becoming involved in most aspects of drug research and development, including gene cloning and parasite cultivation, drug screening, pharmacology and toxicology, lead selection, the conducting of clinical trials of Phases I–III, quality management, ethical and regulatory tasks, but also in various aspects of public health and the implementation of new interventions. Despite his involvement on a broad range of topics and contribution to various diseases, the original and continued passion of Prof. Burri is sleeping sickness (human African trypanosomiasis), where he has significantly contributed to improvement of the treatment. Prof. Burri has been trained as a pharmacist at the University of Bern, Switzerland, holds a PhD in medical parasitology from the University of Basel, and conducted postdoctoral training in molecular pharmacology at the Johns Hopkins University, Baltimore. He has held a Diploma in Pharmaceutical Medicine of the Swiss Association of Pharmaceutical Professionals (SwAPP) since 2000.
